RUO‘ZENLog in
Stocks › Healthcare › COGT

Cogent Biosciences stockCOGT

Cogent Biosciences Inc · Nasdaq
$29.58
−6.07% on the day
close Nov 5, 2026
What is happening with the stock

Cogent Biosciences trades at $29.58, 32.4% below its 52-week high (Dec 8, 2025). The price is below its 50- and 200-day averages, a downtrend. −16.7% year to date, +105.1% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 10, 2026.

Closing price, 6 monthsdetailed chart in the terminal
27.5335.8544.1752-week high 43.73May 8, 2026Nov 5, 2026

Ratings, candles, signals and the screener for COGT — after you log in

Open the terminal
From 52-week high−32.4%
High43.73 Dec 8, 2025
vs 50-day avg−7.4%
vs 200-day avg−16.7%
Year to date−16.7%
12 months+105.1%
Dividend yieldnone
EarningsNov 10
Market cap$5.1B
Chart patternconsolidation
Exchange · sinceNasdaq · 2018

Frequently asked questions about Cogent Biosciences

What is the Cogent Biosciences stock price?

At the close on Nov 5, 2026: $29.58 (−6.07% on the day). 52-week high: $43.73 on Dec 8, 2025. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.

When does Cogent Biosciences report earnings?

The next quarterly report is on Nov 10, 2026. Last quarter, earnings per share changed +12% year over year, revenue 0%.

Does Cogent Biosciences pay dividends?

No, Cogent Biosciences does not pay dividends.

Where does Cogent Biosciences trade and how to buy it?

Ticker COGT, exchange Nasdaq, listed since 2018. You can buy it through a broker with access to US exchanges.

Should I buy Cogent Biosciences now?

We do not give buy or sell advice. Ratings, the detailed chart and signals for COGT are in the terminal after you log in.

Similar stocks

More on COGT

Included in lists